Early wound healing exhibits cytokine surge without evidence of hypoxia

Annals of Surgery

Volumn 231, Issue 1, 2000, Pages 137-147

  Haroon, Zishan A ^c   Raleigh, James A ^a   Greenberg, Charles S ^c   Dewhirst, Mark W ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HISTOPATHOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; WOUND HEALING;

ANIMALS; BENZIMIDAZOLES; CELL DIVISION; CELL HYPOXIA; CYTOKINES; DNA ADDUCTS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FLUORESCENT DYES; KI-67 ANTIGEN; LYMPHOKINES; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PHYSIOLOGIC; NITROIMIDAZOLES; RATS; RATS, INBRED F344; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

EID: 0033962899     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200001000-00020     Document Type: Article

References (63)

1. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315(26):1650-1659.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1(1):27-31.
3. Haroon ZA, Peters KG, Greenberg CS, Dewhirst MW. Angiogenesis and oxygen transport in solid tumors. In: Teicher B, ed. Antiangiogenic agents in cancer therapy. Totowa, NJ: Humana Press Inc.; 1999:3-21.
4. Minchenko A, Salceda S, Bauer T, Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 1994; 40(1):35-39.
5. Patel B, Khaliq A, Jarvis-Evans J, et al. Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem Mol Biol Int 1994; 34(3):639-644.
6. Scannell G, Waxman K, Kaml GJ, et al. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res 1993; 54(4):281-285.
7. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994; 93(4):1564-1570.
8. Ninikoski J, Heughan C, Hunt TK. Oxygen and carbon dioxide tensions in experimental wounds. Surg Gynecol Obstet 1971; 133(6): 1003-1007.
9. Chang N, Goodson WHd, Gottrup F, Hunt TK. Direct measurement of wound and tissue oxygen tension in postoperative patients. Ann Surg 1983; 197(4):470-478.
10. Goodson WHd, Andrews WAS, Thakral KK, Hunt TK. Wound oxygen tension of large vs. small wounds in man. Surg Forum 1979; 30:92-95.
11. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis: effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90(2):262-270.
12. Sakuda H, Nakashima Y, Kuriyama S, Sueishi K. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1. Am J Pathol 1992; 141(6):1507-1516.
13. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359(6398):843-845.
14. Olive PL, Vikse C, Trotter MJ. Measurement of oxygen diffusion distance in tumor cubes using a fluorescent hypoxia probe. Int J Radiat Oncol Biol Phys 1992; 22(3):397-402.
15. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3(2):177-182.
16. Chapman JD, Franko AJ, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer 1981; 43(4): 546-550.
17. Gross MW, Karbach U, Groebe K, et al. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer 1995; 61(4):567-573.
18. Raleigh JA, Miller GG, Franko AJ, et al. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer 1987; 56(4):395-400.
19. Cline JM, Thrall DE, Page RL, et al. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. Br J Cancer 1990; 62(6):925-931.
20. Raleigh JA, Zeman EM, Rathman M, et al. Development of an ELISA for the detection of 2-nitroimidazole hypoxia markers bound to tumor tissue. Int J Radiat Oncol Biol Phys 1992; 22(3):403-405.
21. Lord EM, Harwell L, Koch CJ. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res 1993; 53(23):5721-5726.
22. Azuma C, Raleigh JA, Thrall DE. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiat Res 1997; 148(1):35-42.
23. Raleigh JA, Chou S-C, Arteel GE, Horsman MR. Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H mouse tumors. Radiat Res 1999; 151:580-589.
24. Kennedy AS, Raleigh JA, Perez GM, et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys 1997; 37(4):897-905.
25. Varia MA, Calkins-Adams DP, Rinker LH, et al. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 1998; 71(2): 270-277.
26. Raleigh JA, Calkins-Adams DP, Rinker LH, et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 1998; 58(17):3765-3768.
27. Arteel GE, Raleigh JA, Bradford BU, Thurman RG. Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. Am J Physiol 1996; 271(3 Pt 1):G494-G500.
28. Arteel GE, Iimuro Y, Yin M, et al. Chronic enterai ethanol treatment causes hypoxia in rat liver tissue in vivo. Hepatology 1997; 25(4): 920-926.
29. Stachlewitz RF, Arteel GE, Raleigh JA, et al. Development and characterization of a new model of tacrine-induced hepatotoxicity: role of the sympathetic nervous system and hypoxia-reoxygenation. J Pharmacol Exp Ther 1997; 282(3):1591-1599.
30. Zhong Z, Arteel GE, Connor HD, et al. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998; 275(Renal Physiol 44):F595-F604.
31. Cline JM, Thrall DE, Rosner GL, Raleigh JA. Distribution of the hypoxia marker CCI-103F in canine tumors. Int J Radiat Oncol Biol Phys 1994; 28(4):921-933.
32. Rojas A, Joiner MC, Hodgkiss RJ, et al. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys. Int J Radiat Oncol Biol Phys 1992; 23(2):361-366.
33. Durand RE, Raleigh JA. Identification of nonproliferating but viable hypoxic cells in vivo. Cancer Res 1998; 58:3547-3550.
34. Olive PL. Distribution, oxygenation, and clonogenicity of macrophages in a murine tumor. Cancer Comm 1989; 1:93-100.
35. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75(6):816-821.
36. Sheehan D, Hrapchak B. Theory and practice of histotechnology, 2nd ed. Columbus, OH: Battelle Press; 1980.
37. Freyer JP, Sutherland RM. A reduction in the in situ rates of oxygen and glucose consumption of cells in EMT6/Ro spheroids during growth. J Cell Physiol 1985; 124(3):516-524.
38. Howdieshell TR, Riegner C, Gupta V, et al. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Ann Surg 1998; 228(5):707-715.
39. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77(6):956-964.
40. Shoji M, Hancock WW, Abe K, et al. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 1998; 152(2):399-411.
41. Gentry PA. The mammalian blood platelet: its role in haemostasis, inflammation and tissue repair. J Comp Pathol 1992; 107(3):243-270.
42. Mohle R, Green D, Moore MA, et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 1997; 94(2):663-668.
43. Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 1992; 119(5):1017-1021.
44. Derynck R. Transforming growth factor alpha. Cell 1988; 54(5):593-595.
45. Raines EW, Ross R. Platelet-derived growth factor. I. High-yield purification and evidence for multiple forms. J Biol Chem 1982; 257(9):5154-5160.
46. Knighton DR, Hunt TK, Thakral KK, Goodson WH 3rd. Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg 1982; 196(4):379-388.
47. Qi J, Kreutzer DL. Fibrin activation of vascular endothelial cells. Induction of IL-8 expression. J Immunol 1995; 155(2):867-876.
48. Contrino J, Goralnick S, Qi J, et al. Fibrin induction of tissue factor expression in human vascular endothelial cells. Circulation 1997; 96(2):605-613.
49. Qi J, Kreutzer DL, Piela-Smith TH. Fibrin induction of ICAM-1 expression in human vascular endothelial cells. J Immunol 1997; 158(4):1880-1886.
50. Ollivier V, Bentolila S, Chabbat J, et al. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood 1998; 91(8):2698-2703.
51. Bochaton-Piallat ML, Gabbiani F, Redard M, et al. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995; 146(5):1059-1064.
52. Desmouliere A, Badid C, Bochaton-Piallat ML, Gabbiani G. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol 1997; 29(1):19-30.
53. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146(1):56-66.
54. Bellamy CO. p53 and apoptosis. Br Med Bull 1997; 53(3):522-538.
55. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours [see comments]. Nature 1996; 379(6560):88-91.
56. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394(6692):485-490.
57. Feng ZC, Roberts EL Jr, Sick TJ, Rosenthal M. Depth profile of local oxygen tension and blood flow in rat cerebral cortex, white matter and hippocampus. Brain Res 1988; 445(2):280-288.
58. 2 tension measurements. Cancer Res 1991; 51(22):6098-6102.
59. Vaupel P, Schlenger KH, Hoeckel M, Okunieff P. Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients. Adv Exp Med Biol 1992; 316:361-371.
60. Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol 1992; 99(2): 177-197.
61. 2? Biochem Pharmacol 1987; 36(20):3487-3494.
62. Brown LF, Detmar M, Claffey K, et al. Vascular permeability factor/ vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 1997; 79:233-269.
63. Kuwabara K, Ogawa S, Matsumoto M, et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A 1995; 92(10):4606-4610. Raleigh, NC